Healthcare & Life Sciences
Ambulatory surgery, specialty physician groups, diagnostics, veterinary platforms and healthcare IT serving payers and providers.
Summit Partners invests $25M–$250M of equity in founder-led middle-market companies. We bring deep sector expertise, a 40-person operating group and a horizon measured in decades rather than quarters.
ScrollSince 1994 we have done one thing: buy good businesses at sensible prices and help management teams make them substantially better. No auction theatre, no financial engineering, no six-quarter exit clocks. Four offices, 42 investment professionals and a single committee that has worked together for over a decade.
Roughly two thirds of our platforms have been majority-family-owned for more than a generation. We structure for the seller's priorities — legacy, employees, timing and tax — not our own.
We complete fewer than four new platforms a year. Each one is preceded by an average of nine months of sector mapping and reference work before the first meeting.
We invest for control but keep management teams in real equity. Median management ownership at exit across our last three funds was 18%.
We only underwrite what we already understand. Every focus area is led by a partner who has operated, financed or chaired businesses in that sector for two decades or more.
Ambulatory surgery, specialty physician groups, diagnostics, veterinary platforms and healthcare IT serving payers and providers.
Precision components, motion control, industrial automation, engineered products and aftermarket service networks.
Cold chain, asset-light third-party logistics, regional distribution, last-mile networks and freight technology.
Vertical SaaS, compliance and workflow platforms, and mission-critical data businesses with durable switching costs.
Specialty lending, wealth and asset platforms, managing general agents, broking and claims technology.
Recurring-revenue B2B services, multi-site platforms, branded consumer and pet care businesses.
A selection of current and realised platform investments. Figures are illustrative, unaudited and shown for design purposes only.
A 42-site ambulatory surgery platform across the Mountain West, built from four acquisitions and a same-store growth programme.
Precision motion-control components for semiconductor and aerospace OEMs. Four bolt-on acquisitions and a full plant lean programme.
Cold-chain third-party logistics operating 26 temperature-controlled facilities, serving food, pharma and life-science shippers.
Compliance and workflow software used by more than 900 regional banks and credit unions, with 97% gross revenue retention.
A specialty lender serving lower-middle-market sponsors, with a $1.4B diversified loan book and a proprietary origination engine.
Multi-site veterinary and specialty pet-care services across 11 states, grown from 14 to 96 locations under our ownership.
Every platform gets a named operating partner, an agreed 100-day plan and access to the full resources of our value-creation group — at no cost to the business. Four disciplines do almost all of the work.
“A spreadsheet will tell you what a business is worth today. Only the people running it can tell you what it is worth in ten years — and that is the number we actually underwrite.”
Charles D. Whitmore · Managing Partner
Pricing architecture, sales-force productivity, territory design and channel expansion — rebuilt before the cost base is touched.
+31% average revenue per repLean manufacturing, plant footprint optimisation, procurement consortium pricing and capacity planning across the group.
+380bps average EBITDA marginERP and data modernisation, pricing analytics, automated management reporting and a hardened security posture.
$46M aggregate annual run-rate savingsC-suite search, incentive redesign, board composition and succession planning built for the next ownership cycle.
41 leadership hires in 2025Four of the firm's eight partners. The same faces appear on every deal committee, every portfolio board and every difficult Tuesday.
Managing Partner
Founded Summit's industrials practice in 1996 and has led 31 platform investments. Chairs the investment committee and sits on six portfolio boards.
Senior Partner · Head of Value Creation
Built the firm's 40-person operating group and has led commercial transformation programmes across more than 60 portfolio companies.
Partner · Healthcare & Life Sciences
Leads healthcare investing and chairs the boards of Caldera Health Group and Kestrel Diagnostics. Joined Summit in 2009.
Partner · Technology & Growth
Leads software and technology investing and chairs the firm's Digital Value Office. Joined Summit in 2019 from a $9B credit platform.
42 investment professionals across New York, London, Singapore and Denver — plus a 40-person operating group that is measured on portfolio outcomes, not on deals closed.
Meet the full teamWhether you are weighing a partnership, taking partial liquidity or allocating capital to the next fund, a partner — not an associate — reads every enquiry.
Considering a majority sale, a recapitalisation or growth equity? Send us a short summary and we will respond within two business days.
transactions@summitpartners.comRequest the latest quarterly report, our diligence pack, or a call with the investor relations team.
ir@summitpartners.com